Tag Archives: Neuropsychiatric

Seroxat Study 329 Opens The Pandora’s Box For All Bogus Anti-Depressant Studies…. — GSK : Licence To (K) ill (Documenting GSK And Seroxat)

http://www.madinamerica.com/2016/05/researchers-deconstruct-ghostwritten-industry-trial-for-antidepressant/ Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant In The News May 14, 2016 Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that … Continue reading

Posted in Clinical Drug Trials | Tagged , , , | 1 Comment

Featured Research (2004) – G. S. Dow et al, The Antimalarial Potential of 4-Quinolinecarbinolamines May be Limited Due to Neurotoxicity and Cross-resistance in Mefloquine-resistant P Falciparum Strains

The clinical potential of mefloquine has been compromised by reports of adverse neurological effects. A series of 4-quinolinecarbinolamines were compared in terms of neurotoxicity and antimalarial activity in an attempt to identify replacement drugs.   Neurotoxicity (MTT [thiazolyl blue reduction] … Continue reading

Posted in Research | Tagged , , , , | Leave a comment

British Mefloquine Veteran Resorts to Legal Action: “They Just Put Everything Down to PTSD”

A large proportion of veterans afflicted by mefloquine toxicosis have unfortunately been misdiagnosed with post-traumatic stress disorder (PTSD). Although the symptoms of mefloquine toxicosis can be similar to PTSD, careful examination by health professionals should result in proper diagnosis and … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , , | Leave a comment

Philippa Tuckman – Lariam for Military Personnel: An Unacceptable Risk

The House of Commons Defence Committee will publish its report An acceptable risk? The use of Lariam for military personnel  on 24thMay. Having both given evidence to the inquiry and carefully considered the submissions of other witness, I am hopeful … Continue reading

Posted in Advocacy, Support | Tagged , , , , , , , , , | Leave a comment

CDC Staff Accused Injured U.S. Veteran of “Malingering” in Response to Official Drug Regulator Safety Warning on Mefloquine

FDA Black Box Warning In 2013 the U.S. Food and Drug Administration (FDA) issued a “black box” warning regarding the safety of the anti-malarial drug mefloquine. This is the most serious warning issued by the FDA, which in this case … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , , , , , , , , | Leave a comment

British Parliamentary Inquiry Report on the Use of Lariam™ (Mefloquine) for Military Personnel to be Published on 24 May 2016

The British Parliament’s Defence Select Committee is publishing its report, “An acceptable risk? The use of Lariam for military personnel” on Tuesday 24 May 2016 at 00.01am. Report This is the Committee’s Fourth Report of Session 2015–16 (HC 567) and it can … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media, Our Stories | Tagged , , , , , , , , , , , , | 1 Comment

Feature Story (2004) – Veterans Affairs Alerts Doctors to Malaria Drug Concerns

WASHINGTON, June 24 (UPI) — The Department of Veterans Affairs is warning doctors to watch for long-term mental problems and other health effects from an anti-malaria drug given to soldiers in Afghanistan and Iraq. The drug is mefloquine, known by … Continue reading

Posted in Advocacy, Media, Support | Tagged , , , , , , | Leave a comment

Roche Shareholders: “Lariam Does Not Fit in with Roche’s Image”

Serious concerns over the safety of mefloquine (Lariam™) have not been limited to veterans, travellers or other consumers who have been adversely affected by the drug’s neurotoxic side effects. For many years, shareholders of the multinational Swiss manufacturer of the … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , | Leave a comment

Stuart McCarthy – Diagnosis and Management of Mefloquine Toxicosis in Military Veterans, Part 1

Mefloquine toxicosis, or “mef tox”, is a serious health problem that probably afflicts many tens of thousands of military veterans globally. The anti-malarial drug mefloquine (or Lariam™), like several other drugs from the same family of synthetic quinolines, is known … Continue reading

Posted in Advocacy, Research, Support | Tagged , , , , , , , | 6 Comments